2015. Treatment with dasatinib or nilotinib in chronic myeloid leukemia patients who failed to respond to two previously administered tyrosine kinase inhibitors - a single center experience . Clinics. 70, 8 (Aug. 2015), 550–555. DOI:https://doi.org/10.6061/clinics/2015(08)04.